A detailed history of Te Ahumairangi Investment Management LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Te Ahumairangi Investment Management LTD holds 201,612 shares of ROIV stock, worth $2.33 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
201,612
Previous 168,145 19.9%
Holding current value
$2.33 Million
Previous $1.78 Million 30.16%
% of portfolio
0.41%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

BUY
$10.17 - $12.5 $340,359 - $418,337
33,467 Added 19.9%
201,612 $2.31 Million
Q2 2024

Aug 13, 2024

SELL
$10.36 - $11.74 $233,100 - $264,150
-22,500 Reduced 11.8%
168,145 $1.78 Million
Q1 2024

May 09, 2024

BUY
$9.87 - $11.8 $321,762 - $384,680
32,600 Added 20.63%
190,645 $2.01 Million
Q4 2023

Feb 12, 2024

BUY
$8.38 - $11.58 $1.32 Million - $1.83 Million
158,045 New
158,045 $1.78 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.15B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Te Ahumairangi Investment Management LTD Portfolio

Follow Te Ahumairangi Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Te Ahumairangi Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Te Ahumairangi Investment Management LTD with notifications on news.